2MIP
CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES
Experimental procedure
| Spacegroup name | P 43 |
| Unit cell lengths | 55.100, 55.100, 138.900 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 6.000 - 2.200 |
| R-factor | 0.176 |
| Rwork | 0.176 |
| RMSD bond length | 0.018 |
| RMSD bond angle | 2.810 |
| Phasing software | X-PLOR |
| Refinement software | TNT |
Data quality characteristics
| Overall | |
| High resolution limit [Å] | 2.200 * |
| Rmerge | 0.066 * |
| Total number of observations | 85564 * |
| Number of reflections | 18007 * |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | Vapor diffusion, hanging drop * | 7.4 * |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | drop | protein | (mg/ml) | |
| 2 | 1 | drop | 0.02 (%) | ||
| 3 | 1 | reservoir | DMSO | 4-6 (%) |






